Defective interfering (DI) RNAs of Berne virus (BEV) were generated by serial undiluted passaging of the virus in embryonic mule skin cells. Two DI RNAs of 1.0 and 1.4 kb (designated DI1000 and DI1400) were characterized in more detail. Isokinetic sucrose gradient analysis showed that these DI RNAs are specifically packaged into particles with smaller S values than standard virions. Both DI RNAs were cloned and sequenced. Three genomic cDNA clones were identified using probes complementary to the 5' end of a DI RNA, which are thought to be derived from the 5'-terminal region of the BEV genome. A non-translated region of about 700 nt and the 5' end of the putative BEV replicase gene were identified in the consensus nucleotide sequence. Both DI RNAs were shown to contain sequences from the 5' and 3' ends of the BEV genome. A conserved sequence motif, which has been postulated to be involved in sub-genomic RNA transcription, was also identified just downstream of the extreme 5' ends of DI1000 and DI1400.
Introduction
Berne virus (BEV) is the type species of a group of enveloped positive-strand RNA viruses, the toroviruses (Horzinek & Weiss, 1984; Horzinek et al., 1987) , which has recently been recognized (by the International Committee on Taxonomy of Viruses) as 'a new genus with possible affinities to the coronavirus family'. During the past 4 years, analysis of the BEV genome structure and replication strategy has revealed that toroviruses are evolutionarily related to coronaviruses. The size (25 to 32 kb), organization and expression of the genomes of BEV (Snijder et al., 1990c and coronaviruses (for a review, see Spaan et al., 1988) are similar. In addition, their putative replicase proteins contain several homologous domains (Snijder et al., 1990a) and the BEV envelope proteins display the same structural features as their coronaviral counterparts (Snijder et al., 1990b; den Boon et al., 1991) .
Both corona-and toroviruses synthesize a 3'-coterminal nested set of subgenomic (sg) mRNAs to express the open reading frames (ORFs) which are located in the Y-terminal one-third of the genome. The coronaviral RNAs are also 5'-coterminal; each sgRNA contains a leader sequence of about 60 to 75 nucleotides (nt) which is identical to the 5' end of the genome (for a review, see Spaan et al., 1988) . A conserved nucleotide sequence is present at the sites where the coronaviral leader is joined to an mRNA body . However, the exact mechanism of this discontinuous transcription, which also involves the synthesis of negative-strand sgRNAs (Sethna et al., 1989; Sawicki & Sawicki, 1990 ), remains to be elucidated.
In contrast, analysis of the 5' end of the smallest BEV sgRNA (RNA5) indicated that there is unlikely to be a common leader sequence at the 5' end of toroviral RNAs (Snijder et al., 1990c) . However, sequence information from the 5'-terminal region of the BEV genome, which is a prerequisite for more detailed study of BEV transcription, has not been available until now. Only the sequence of the T-terminal 14.5 kb of the BEV genome has been determined previously (Snijder et al., 1990a, c) .
The supernatant of BEV-infected cells has repeatedly been shown to contain two classes of virus-specific material (Horzinek et al., 1985; Snijder et al., 1988) . Sucrose gradient analysis revealed that, in addition to the infectious virion (400S; 1-16 g/ml in sucrose), BEV harvests contained virus-specific particles which differed in density (1-07 to 1.11 g/ml in sucrose) and sedimentation behaviour (50S to 100S). The presence of small BEV-specific RNAs in this '50S fraction' indicated that this material may consist of particles which contain defective interfering (DI) RNAs.
DI RNAs are mutant viral genomes which have lost the potential to replicate autonomously. Their replication depends on enzymes encoded by standard virus. They replicate more efficiently than genomic RNAs, which is usually due to their smaller size. Together with competition for viral structural components, the replicative advantage of DI RNAs results in inhibition of standard virus replication. Since DI RNAs have retained the sequences required for replication and packaging, they can be used to study these cis-acting signals (Levis et al., 1986; Hagino-Yamagishi & Nomoto, 1989; Makino & Lai, 1989; Pattnaik & Wertz, 1990) .
In the present report, we describe the generation, packaging and sequence analysis of two BEV DI RNAs. Our results indicate that the previously described heterogeneous nature of BEV harvests was due to the generation of DI RNA-containing particles. In addition, sequence information from the Y-terminal region of the BEV genome was obtained, which will be important for future studies on toroviral transcription and replication.
Methods
Generation ofDl RNAs. Berne virus (strain P138/72) was grown in embryonic mule skin (EMS) ceils as described previously (Weiss et al., I983; Snijder et al., 1988) . DI RNAs were generated as follows. EMS cells (106 cells in 10 cm 2 Petri dishes) were infected using two cloned BEV stocks (A and B) at an m.o.i, of I and incubated at 37°C. At 20 h post-infection (p.i.), the virus-containing culture medium (1 ml) was harvested [passage 1 (P 1) virus] and subsequently half of it was used to infect a new monolayer of EMS cells. This procedure was repeated until P6 had been reached. In addition, intracellular RNA was isolated from the same cells after each passage (Snijder et al., 1988) . Titrations of BEV infectivity were performed as described previously (Weiss et al., 1983) .
Preparation and purification of RNA. One ml of P6 virus supplemented with helper virus (m.o.i. 10) was used to infect a 160 cm 2 bottle of EMS cells. At 30 h p.i., virns-containing medium (P7) was harvested and cells were lysed. The isolation and poly(A) selection of intracellular RNA has been described before (Snijder et al., 1988) . RNA was isolated from DI particle-containing virus preparations and sucrose gradient fractions (see below) by phenol extraction and ethanol precipitation.
RNA electrophoresis, Northern blot hybridization and hybridization in
gels. Formaldehyde/formamide RNA electrophoresis in 1% agarose gels and Northern blotting were performed as described before (Snijder et al., 1990 c) . Northern blot hybridizations and direct hybridizations in gels with various synthetic oligonucleotides were carried out at 5 °C below Tm under the conditions described by Meinkoth & Wahl (1984) . Hybridizations with oligo D (a 12-mer; Fig. 6 ) were carried out at 22 °C, 10 °C below its calculated Tin.
Sucrose gradient analysis of virus harvests. At 30 h p.i. virus (PS) was harvested from a 75 cm 2 bottle of EMS cells which had been infected with 1 ml of P7 DI particle-containing virus (see above) supplemented with standard virus (m.o.i. 10). A control culture was infected with standard virus only. Metabolic labelling was performed by adding 50 laCi/ml [3H]uridine from 16 to 30 h p.i. Virus harvests were concentrated as described (Snijder et al., 1988) and centrifuged in isokinetic 10 to 25.5% sucrose gradients (van der Zeijst & Bloemers, 1976) at 41000 r.p.m, for 40 min at 5 °C (Beckman SW41 rotor).
eDNA synthesis, cloning and sequencing. Poly(A)-selected DI RNAcontaining RNA from BEV-infected EMS cells (P7) was used as a template for the preparation of eDNA. Procedures for first-and second-strand eDNA synthesis and cloning of eDNA in vector pUC9 have been described before (Snijder et al., 1990c) . eDNA synthesis was primed with oligo(dT) or an oligonucleotide which is complementary to the BEV sequence from 18 to 32 nt upstream of the poly(A) tail (oligo E; see Fig. 4a ). Subcloning in M13 vectors and nucleotide sequence analysis were carried out as described before (Snijder et al., 1990c) .
Selection of DI RNA-specific cDNA clones. BEV-specific cDNA clones were selected by colony hybridization with oligo E (see above). Subsequently, a hybridization with an oligonucleotide which is complementary to a sequence from the 5' end of the BEV N protein gene (oligo A; Snijder et al., 1990c) identified clones which were most likely to be derived from standard BEV sgRNAs. The potential DI RNA clones remaining were analysed by restriction enzyme and sequence analysis.
Primer extension. Ten ng of a kinase-labelled synthetic oligonucleotide with the sequence 5' CAGATTCCTACACAG 3' (oligo F; see Fig.  4a ) was annealed to 0.5 lxg of poly(A)-selected RNA from BEV-(stock A or B; P7) or mock-infected EMS cells in the presence of 10 mMmethylmercuric hydroxide. Primer extension and electrophoretic analysis of extension products have been described before (Snijder et al., 1990c) . Oligo F-primed dideoxynucleotide sequencing samples, made from an M13 template that contained the 5' end of the cDNA insert of clone DI32, were used as markers.
Results

Generation of BEV DI RNAs
DI RNAs were generated by serial undiluted passaging of BEV stocks A and B in EMS cells. After each passage, intracellular RNA was isolated and analysed by Northern blot hybridization with an oligonucleotide complementary to the 3' end of the BEV genome sequence (oligo E; see Fig. 4a ). The hybridization results revealed the generation of several new BEV-specific RNAs during undiluted passaging.
After four passages of BEV stock A, an intracellular RNA of about 1-0 kb was detected ( Fig. 1 a, lane 4) , which became more prominent upon an additional passage. Furthermore, a significant inhibition of BEV standard sgRNA synthesis was observed at this stage ( Fig. 1 a, lane 6 ) ~. After P8 of stock A, an additional RNA, which comigrated with BEV RNA5, was detected in this virus preparation (see below and Fig. 3c ).
During undiluted passaging of BEV stock B, a population of at least three novel RNA species was generated. A 1-4 kb RNA was detected in cells infected with P1 virus, which virtually comigrated with BEV sgRNA4 (Fig. 1 b, lane 2) . Subsequent passages demonstrated increasing amounts of this 1.4 kb species ( Fig. 1 b , lanes 3 to 6) and additional bands at 1.2 kb (lanes 5 and 6) and 0.8 kb. Due to its comigration with BEV sgRNA5, the 0.8 kb species was only detected when DI RNAspecific probes were used (see below and The detection of new RNA species coincided with the inhibition of the synthesis of standard sgRNAs ( Fig. 1 a, b) and with lower infectivity titres in the cell culture medium (Fig. I c) . A 10-fold reduction of standard virus infectivity titres was observed between P4 and P6 in both experiments. Moreover, the novel RNAs were found to be non-coUinear with the BEV genome. Oligo A, which is complementary to a sequence from the 5' end of the BEV N protein gene [634 to 620 nt upstream of the poly(A) tail; Snijder et al., 1990c] , should have reacted with a 1.0 kb RNA which is collinear with the 3' end of the genome. As shown in Fig. 2 however, oligo A reacted with only the standard BEV sgRNAs (lane 1), whereas oligo E (the 3' BEV oligo) recognized both new and standard BEV RNAs (lane 2). Similar results were obtained with the 1.4 kb RNA which was generated during the passaging of virus stock B (data not shown). Titrations of BEV infectivity recovered from the fractions of the sucrose gradients described in (a). Gradient fractions were pooled two by two and infectivity titres (in TCID5o; n = 10) were determined as described by Weiss et al. (1983) . ( 
Packaging of B E V DI RNAs
The packaging of the novel 1.0 kb RNA from virus stock A (designated D11000) was studied by isokinetic sucrose gradient analysis of DI1000-containing virus. From similar experiments the sedimentation coefficient of standard BEV was known to be approximately 400S (Koopmans et al., 1986) . Fig. 3a shows the result of a [3H]uridine RNA labelling experiment in which DI1000-containing (P7) and DI-free virus stocks were used to infect EMS cells at a similar m.o.i. Sucrose gradient analysis of the medium from the DI-free infection revealed a prominent peak of [3H]uridine incorporation around the 400S position (Fig. 3a) . This material also contained the bulk of viral infectivity (Fig. 3 b) . The 400S peak was considerably smaller in the experiment with the DI 1000-containing virus stock; instead, a broad peak of uridine incorporation into non-infectious material with sedimentation values between 75S and 200S was observed (Fig. 3a, b ).
The infection with the DI1000-containing virus preparation was repeated without metabolic RNA labelling. Subsequently, RNA was isolated from infected cells, cell culture medium, and both 400S and 100S gradient fractions. Northern blot hybridization (Fig. 3 c) using oligo E (the 3' BEV oligo) as a probe revealed that DI1000 is not packaged into standard virus particles; DI1000 was recovered exclusively from the 100S gradient fraction. Although the 400S fraction did contain the infectivity peak (Fig. 3b) , hardly any BEV genomic RNA could be detected after Northern blot hybridization of RNA from this fraction (Fig. 3c) . This is explained by the interfering effect of DI1000 on the replication of the standard virus and by the poor blotting efficiency of the large BEV genome (Snijder et al., 1990c) . Small amounts of an RNA species which comigrated with BEV RNA5 were detected in total culture supernatant and in the 100S fraction. This new band is assumed to be an additional DI RNA since it reacted with DI RNA-specific probes (oligo F; see below). Similar results were obtained when the packaging of the novel 1.4 kb RNA species (designated DI1400) from virus stock B was studied (data not shown).
From their interference with BEV replication, their non-collinearity with the viral genome, and their specific packaging into particles with smaller S values than standard virions, D11000 and DI1400 were concluded to be DI BEV RNAs. . 
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Sequence analysis of DIIO00 and DH400
Oligo(dT)-and oligo E-primed cDNA libraries were prepared from poly(A)-selected RNA from EMS cells which had been infected with DI particle-containing (P7) BEV stocks A or B. Potential DI cDNA clones were selected on the basis of a positive hybridization signal with oligo E, a negative result with oligo A, and the lengths of their cDNA inserts. The presence of a PstI restriction site (Fig. 4) The nucleotide sequence analyses of inserts of overlapping DII000 and DI1400 cDNA clones are presented in Fig. 4 (a) and (b) , respectively. To study the 5' end of the DI RNAs in more detail, oligo F (complementary to a sequence about 130 nt downstream of the 5' end of the DI1000 sequence; Fig. 4a and Fig. 2, lane 3) was used for primer extension analysis. Using DI1000-or DI 1400-containing intracellular RNA, oligo F extension produced identical results; two prominent extension products (145 and 146 nt long) were detected (Fig. 5,  lanes 1 and 2) . The cDNA insert of clone DI32, a DI1000 cDNA clone whlch was used as a marker, was found to lack only one or two nt from the 5" end of the DI RNA.
To confirm that the primer extension products described above did indeed represent the 5' end of the BEV DI RNAs, oligo F was used to prime the singletrack sequence analysis of 32 DI1000 and DI1400 cDNA clones (data not shown). The 5' ends of three of these clones mapped to nt position 1 or 2 in the DII000 sequence and therefore corresponded to one of the primer extension products. Two clones extended beyond the presumed 5' end, but sequence analysis revealed that they contained inverted repeats of downstream sequences and they were therefore regarded as 'snap-back' artefacts of cDNA synthesis. Remarkably, the 3' ends of these artefacts also mapped to nt position 1 or 2 in the DI1000 sequence.
We assume that the DI 1000 sequence presented in Fig.  4(a) is almost full-length; it extends from the 3' poly(A) tail to the third nt downstream of the primer extension endpoint. If DI1000 and DI1400 are completely 5'-and Y-coterminal, the consensus sequence of D I 1400 lacks 21 and 52 nt at its 5' and 3' ends, respectively (Fig. 4b). upstream of the putative ORFla AUG codon) with remarkable sequence similarity to the conserved 'core promoter' sequence is underscored (c). The nucleotide sequence reported in (c) has been submitted to the EMBL nucleotide sequence database and has been assigned the accession number X56016. Fig. 6 . Alignment of putative BEV 'core promoter' sequences and their context. The sequences for RNAs 2 to 5 have been described previously (Snijder et al., 1990c) . The sequences complementary to oligonucleotides used in this and previous studies (Snijder et al., 1990c) have been indicated. Oligo B is thought to represent the 5' end of BEV RNA5 (Snijder et al., 1990c) . Fig. 5 . Primer extension analysis of the 5' end ofBEV DI RNAs. Oligo F (see Fig. 4a ) was extended using total intracellular RNA from cells infected with DI1000-(lane l) and DIl400-containing (lane 2) virus stocks. RNA from mouse hepatitis virus-infected cells served as a negative control (lane 3). Oligo F-primed dideoxynucleotide sequencing samples of clone D132 (see Fig. 4a ) were used as a marker. The 'core promoter' region and the dG tail in the DI32 sequence (both complementary) are indicated.
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The 5' end o f B E V D I R N A s contains a conserved nucleotide sequence
No 'common leader'-containing e D N A clones, which were readily detected in coronaviral e D N A libraries, could be identified in e D N A libraries prepared from BEV m R N A s (Snijder et al., 1990c) . Nevertheless, a conserved nucleotide sequence was identified upstream of each of the BEV ORFs which are present in the 3' part of the genome (Snijder et al., 1990e ; see also Fig. 6 ). Primer extension and Northern blot analysis of the smallest BEV R N A (RNA5) indicated that its extreme 5' end contains this conserved sequence motif and two upstream nucleotides (Snijder et al., 1990c) . The BEV R N A s therefore appear to lack a common leader sequence of the size which has been found in coronaviruses. The conserved BEV motif was postulated to function as a 'core promoter' during the internal initiation of sgRNA transcription (Snijder et al., 1990c) . However, since no data on the 5' ends of other BEV R N A s were available, the presence of a small common leader sequence (e.g. encompassing the conserved sequence and some upstream nucleotides) could not be excluded. The putative 'core promoter' sequence was also detected near the 5' end of the BEV DI R N A s (Fig. 6) . Nueleotide sequence and primer extension analysis ( Fig.  4a and 5 ) indicated that the DI R N A s contain five or six nt upstream of this conserved sequence.
An oligonucleotide complementary to the 'core promoter' region at the 5' end of DI1000 (oligo D; Fig. 6 ) was used for hybridization analysis. Oligo D reacted with all DI R N A s and did not recognize the standard subgenomic BEV R N A s (Fig. 2, lanes 4 and 5) . However, oligo D failed to recognize BEV RNA1 when samples derived from DI-free infections were analysed (data not shown). 
Identification of cDNA clones from the 5" end of the B E V genome and composition of B E V DI RNAs
An AccI-PstI restriction fragment from the 5' end of clone DI06 (Fig. 4a ) was used to screen a random-primed BEV cDNA library (Snijder et al., 1990c) for clones which might contain sequences from the 5'-terminal region of the BEV genome. Three partially overlapping clones were identified and sequenced. The 5"-terminal part of an ORF, starting with an ATG codon (positions 825 to 827 in Fig. 4c ) and continuing for at least 750 nt, was identified (Fig. 4c) .
The 5' end of the putative genomic consensus sequence presented in Fig. 4 (c) mapped to nt position 124 in the D11000 sequence. The DI 1000 sequence is collinear with the genomic sequence between nt positions 124 to 607 ( Fig. 4a and 7) . DI1000 contains 242 nt [excluding the poly(A) tail] from the 3' end of the genome.
The entire nucleotide sequence of DI1000 is also present in DI1400 (Fig. 7) . However, the sequences derived from the 5'-and 3'-terminal parts of the genome are somewhat larger, 712 and 441 nt, respectively, in this DI RNA. Compared with DI1000, DI1400 contains a 100 nt insertion which connects the 5'-and T-terminal parts of the molecule. This sequence could not be identified in the currently available BEV sequences; if it is virus-specific, it must have been derived from the 5' part (ORFla) of the replicase gene ( Fig. 4b and 7) .
Discussion
The heterogeneous nature of BEV harvests from cell culture has been described previously (Horzinek et al., 1985; Snijder et al., 1988) . In addition to the virion peak, at least one other peak of BEV-specific material was regularly observed in sucrose gradients run under both isokinetic and isodensity conditions. The latter material, sometimes referred to as '50S particles', was observed in both protein and RNA metabolic labelling experiments. It was known to contain BEV proteins, albeit in ratios differing from those in the virion peak (Horzinek et al., 1985) , and small RNA molecules which did not comigrate with standard BEV sgRNAs (J. Ederveen & E. J. Snijder, unpublished results). The hybridization experiments and sequence analysis presented in this paper identify these RNA molecules as DI RNAs of BEV and indicate that the '50S material' contains DI particles of BEV.
BEV DI particles display both smaller S values (Fig.  3a) and considerably lower densities than standard virions [1.07 to 1-11 g/ml versus 1.16 g/ml in sucrose (Horzinek et al., 1985; Snijder et al., 1988) ]. The data on the protein composition of the BEV DI particles are rather puzzling; both the nucleocapsid and peplomer proteins have been found to be either absent, or present in very small quantities, in '50S material' (Horzinek et al., 1985; J. Ederveen & E. J. Snijder, unpublished results) . This observation conflicts with the current definition of DI particles; they may be smaller (e.g. rhabdoviruses; for a review see Holland, 1987) and of different density [e.g. picornaviruses (Cole, 1973) ] than standard virions, but they must contain the same structural proteins (Huang, 1986) . Large scale preparations of purified BEV DI particles are probably required to resolve this point, but such an experiment may be difficult in view of the limitations of the currently available BEV culture system. BEV DI RNAs are readily generated during undiluted passaging of the virus in EMS cells. DII000 and DI1400 both were found to contain sequences from the 3' and the putative 5' end of the genome (Fig. 7) . Evidence that the 5'-terminal region of BEV DI and genomic RNAs contain related sequences was obtained by sequencing random-primed genomic cDNA clones which reacted with a probe from the 5' part of DI1000. From the analysis and comparison of DI-specific and genomic sequence data several interesting observations could be made.
The 5" parts of DI1000 and DI1400 contain sequences (at least 479 and 589 nt, respectively) which are also found in the putative 5' end of the genome. This suggests that this area contains signals that are indispensable for BEV RNA replication. A putative transcription-regulating sequence, which is present upstream of BEV ORFs 2 to 5 (Snijder et al., 1990c; Fig. 6) , was detected just downstream of the extreme 5' end of the DI sequence ( Fig. 4a and 6 ). Although experimental data are not available, the presence of the 'core promoter' sequence at that position seems to underline its importance. The first 600 nt of the DI sequence must also include an RNA encapsidation signal; only DI RNAs, and not the standard BEV sgRNAs, were recovered from the supernatant of infected cells (Fig. 3 c) .
A substantial part (about 750 nt) of an ORF was identified in the 3' part of the newly obtained genomic sequence. The amino acid sequence translated from this partial ORF (Fig. 4c) probably represents the Nterminal part of the BEV replicase (ORF 1 a). At least 700 nt from the 5' end of the genomic sequence appear to remain untranslated; there are no translation initiation codons and all reading frames contain multiple stop codons. The largest uninterrupted potential reading frame runs from nt positions 516 to 766 (Fig. 4c) but does not contain an AUG codon. Extension of the sequence with the Y-terminal 123 nt of the DI1000 sequence (although not justified by experimental data at this moment, see below) would not change the situation; only one AUG codon (nt position 22 to 24; Fig. 4a ) is present in this DI sequence and it is followed by multiple stop codons in all reading frames (Fig. 4a) . In view of the economy of the BEV genome (consecutive ORFs are either partly overlapping or separated by short intergenic sequences), a non-translated region of this size is expected only at the 5' (or 3') end of the genome. The absence of AUG codons upstream of the ORFla initiation codon is probably a prerequisite of efficient initiation of translation by scanning ribosomes (Sonenberg, 1988; Kozak, 1989) . Computer-assisted analysis of the non-translated BEV sequence did not reveal the potential to fold into a picornavirus-like Y-terminal structure, which allows internal initiation of translation (Skinner, 1989) .
Remarkably, a sequence which is very similar to the conserved putative 'core promoter' sequence was detected in the genomic cDNA clones 70 to 63 nt upstream of the putative replicase AUG codon (5; UCUUUAGA 3'; Fig. 4c and 6 ). This finding implies that the AUG codons of all BEV ORFs are preceded by a similar sequence. Although the observed sequence similarity may occur by chance, it could also be taken as an indication of an alternative function of the conserved sequence; at this moment a role in the regulation of translation cannot be excluded.
All coronaviral DI RNAs analysed to date have been found to contain the coronaviral leader sequence (Makino et al., 1988 (Makino et al., , 1989 van der Most et al., 1991) . Therefore, they are 5'-coterminal with the genomic and sgRNAs of the standard virus. The results presented in this study indicate that BEV DI1000 and DI1400 are not Y-coterminal with BEV sgRNA5; oligo D reacted with all DI RNAs but did not recognize RNA 5 (or any other standard sgRNA; Fig. 2, lanes 4 and 5) . In addition, the number of nucleotides upstream of the conserved sequence motif was found to be different [two nt in BEV RNA5 (Snijder et al., 1990c) ; five to six nt in DI1000 and DI1400 (Fig. 5)] . None of the 32 independent DI cDNA clones, which were analysed by single-track sequencing, contained unique additional sequences at the 5' end.
The results described above seem to corroborate the absence of a common leader sequence in toroviral RNAs. However, the extreme 5' end of the DI1000 sequence (123 nt) was not present in the genomic cDNA clones and therefore no conclusions on the collinearity of DI and genomic RNAs in this region can be drawn. The fact that oligo D did not hybridize to RNA1 indicates that there are differences between the sequences near the 5' ends of DI and genomic RNA. Since point mutations, insertions and deletions in the 5' end of DI RNAs have been described before, e.g. for coronaviruses (Makino et al., 1988) , the conclusion that toroviral RNAs do not contain a common Y-terminal sequence would be premature. Both the results obtained with oligo D and the varying number of nucleotides upstream of the 'core promoter' motif could be explained by mutations in the 5' end of the DI RNA. Using the polymerase chain reaction technique (anchored PCR) we hope to be able to specifically clone and compare the 5' ends of BEV genomic and subgenomic RNAs in the near future.
